These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 1301797

  • 1. Cataract in renal transplantation recipients with combination ciclosporin treatment.
    Nishimoto K, Sasaki K, Yamamura T, Ishikawa I, Shinoda A.
    Lens Eye Toxic Res; 1992; 9(3-4):455-67. PubMed ID: 1301797
    [Abstract] [Full Text] [Related]

  • 2. Influence of cyclosporin on steroid-induced cataracts after renal transplantation.
    Nakamura T, Sasaki H, Nagai K, Fujisawa K, Sasaki K, Suzuki K, Tsugawa R.
    Jpn J Ophthalmol; 2003; 47(3):254-9. PubMed ID: 12782160
    [Abstract] [Full Text] [Related]

  • 3. [Effect of immunosuppressive treatment on the crystalline lenses of patients after kidney transplantation].
    Dróbecka-Brydakowa E.
    Klin Oczna; 1991 Dec; 93(12):332-3. PubMed ID: 1819669
    [Abstract] [Full Text] [Related]

  • 4. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M, Weinstein T, Korzets A, Chagnac A, Ori Y, Zevin D, Malachi T, Gafter U.
    J Lab Clin Med; 2001 Jan; 137(1):14-20. PubMed ID: 11150019
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppression in live-related donor renal transplantation.
    Iman A, Rao M, Juneja R, Jacob CK.
    Natl Med J India; 2001 Jan; 14(2):75-80. PubMed ID: 11396322
    [Abstract] [Full Text] [Related]

  • 6. Ocular side effects of systemic steroid therapy in renal transplant patients.
    Debnath SC, Abomelha MS, Jawdat M, Chang R, Al-Khader AA.
    Ann Ophthalmol; 1987 Nov; 19(11):435-7. PubMed ID: 3322137
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C, Eberl T, Riedmann B, Pernthaler H, Ofner D, Königsrainer A, Margreiter R.
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [Abstract] [Full Text] [Related]

  • 8. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 9. [Influence of cyclosporin on steroid-induced cataract].
    Nakamura T, Sasaki H, Nagai K, Fujisawa K, Sasaki K, Suzuki K, Tsugawa R.
    Nippon Ganka Gakkai Zasshi; 2001 Jul; 105(7):478-82. PubMed ID: 11510113
    [Abstract] [Full Text] [Related]

  • 10. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [Abstract] [Full Text] [Related]

  • 11. Annual trends and triple therapy--1991-2000.
    Nishikawa K, Terasaki PI.
    Clin Transpl; 2001 Dec; ():247-69. PubMed ID: 12211788
    [Abstract] [Full Text] [Related]

  • 12. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
    Isoniemi H, Ahonen J, Eklund B, Höckerstedt K, Salmela K, von Willebrand E, Häyry P.
    Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
    [Abstract] [Full Text] [Related]

  • 13. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
    Keitel E, Bittar AE, Losekann A, Deboni L, Ceretta F, Goldani JC, Garcia VD.
    Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
    [No Abstract] [Full Text] [Related]

  • 14. Posterior subcapsular cataracts induced by topical corticosteroids following keratoplasty for keratoconus.
    Donshik PC, Cavanaugh HD, Boruchoff SA, Dohlman CH.
    Ann Ophthalmol; 1981 Jan; 13(1):29-32. PubMed ID: 7018341
    [Abstract] [Full Text] [Related]

  • 15. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [Abstract] [Full Text] [Related]

  • 16. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H, Malaise J, Illner WD, Tarabichi A, Dieterle C, Landgraf R, Land W, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [Abstract] [Full Text] [Related]

  • 17. HLA-A1 and steroid-induced cataracts in renal transplant patients.
    Kollarits CR, Swann ER, Shapiro RS, Gillespie CM, Shealy TA.
    Ann Ophthalmol; 1982 Dec; 14(12):1116-8. PubMed ID: 6762131
    [Abstract] [Full Text] [Related]

  • 18. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H, Otte B, Lang D, Heidenreich S.
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [Abstract] [Full Text] [Related]

  • 19. Ocular and visual side effects of systemic cyclosporine.
    Apaydin C, Gur B, Yakupoglu G, Saka O.
    Ann Ophthalmol; 1992 Dec; 24(12):465-9. PubMed ID: 1485743
    [Abstract] [Full Text] [Related]

  • 20. Ocular complications in renal transplant recipients.
    Pavlin CR, deVeber GA, Cook GT, Chisholm LD.
    Can Med Assoc J; 1977 Aug 20; 117(4):360-2. PubMed ID: 329970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.